Violin Jonathan 4
4 · Viridian Therapeutics, Inc.\DE · Filed Feb 3, 2023
Insider Transaction Report
Form 4
Violin Jonathan
President and COO
Transactions
- Sale
Common Stock
2023-02-02$36.80/sh−50,000$1,840,000→ 430,905 total
Footnotes (1)
- [F1]This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $36.1523 to $37.3689. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.